Enrollment for FP-101 Phase II Clinical Trials are Now Completed

Fervent Pharmaceuticals is pleased to announce we’ve completed the enrollment stage of our Phase II Clinical Trial for FP-101.

FP-101, our upcoming product, is a non-hormonal, non-herbal, and non-antidepressant treatment for the vasomotor symptoms many women experience during menopause, like hot flashes and night sweats.

Visit www.FerventPharma.com to learn more about how we’re working to improve women’s lives.

To learn more about how Fervent Pharmaceuticals is making a positive impact on women’s health, get in touch using our contact form or email us at info@ferventpharmaceuticals.com